Nomura
http://www.nomura.com/Nomura (NYSE: NMR) is a global investment banking and securities firm. The firm’s operations include Domestic Retail, Global Markets, Global Investment Banking, Global Merchant Banking, and Asset Management. Nomura is headquartered in Tokyo, Japan.
Nomura is represented in the Americas by Nomura Holding America (NHA). NHA’s major divisions are Fixed Income, Investment Banking, Equities and Asset Management.
View Older Stories View More Recent Stories
-
Pre-Open Stock Movers 04/06: (QURE) (CYTX) (TSLA) Higher; (DGLY) (HLF) (QCOM) Lower (more...)
-
Nomura Securities Upgrades VMware (VMW) to Buy; Sentiment Overly Negative
-
Axalta Coating Systems (AXTA) Prices Upsized Common Offering at $28/Share
-
Axalta Prices Secondary Offering
-
Nomura Securities Downgrades Nucor (NUE), Steel Dynamics (STLD) to Neutral
-
Fitch Rates Nomura Resecuritization Trust 2015-4R
-
Nomura Securities Starts Flowserve Corp. (FLS) at Neutral
-
Nomura Securities Starts Dover Corp. (DOV) at Buy
-
Nomura Securities Starts Honeywell International (HON) at Neutral
-
Form 6-K NOMURA HOLDINGS INC For: Mar 31
-
Neo4j Powers Master Data Management (MDM) Applications for Enterprises Across the Globe
-
ACE Ltd (ACE) PT Lifted to $132 at Nomura; Top Long-Term Holding
-
Palo Alto Networks (PANW) Bullish Stance Reiterated at Nomua Following Ignite Conference
-
Nomura Research Institute to Acquire Brierley+Partners, a leader in Loyalty and CRM Services
-
Axalta Coating Systems (AXTA) Commences 35M Secondary Offering
-
Axalta Commences Secondary Offering
-
Lincoln International Hires Hideaki Harashima as Managing Director in Tokyo
-
Notable Analyst Rating Changes 3/30: (BRCM) (ADI) (GPRO) Upgraded; (ALTR) (BBEP) (XLNX) Downgraded
-
St. Mary's is Texas' first Fair Trade University
-
Pre-Open Stock Movers 03/30: (ICEL) (ASPX) (CTRX) (HZNP) Higher; (CANF) (BDSI) (ADMP) Lower (more...)
-
Nomura Lists Five Reason Visa (V) Could Have Upside to Estimates
-
Nomura Securities Starts Tekmira Pharma (TKMR) at Buy, $32 PT
-
MultiVir Files Registration Statement for Proposed Initial Public Offering
-
Nomura Securities Starts Retrophin (RTRX) at Buy
-
Nomura Securities Upgrades Broadcom (BRCM) to Buy
-
Bellagio Celebrates Japanese Culture with Vibrant Spring Conservatory Display and Art Installation by Renowned Sculptor Masatoshi Izumi
-
Nomura Remains Buyers of Intercept Pharmaceuticals (ICPT) Following Meetings with Management
-
Restoration Hardware (RH) Bullish Stance Reiterated at Nomura Securities Post Q4
-
Messenger, Video Ad Focus Supports Facebook's (FB) Growth Trajectory, Nomura Securities Says
-
Nomura Weighs in on Baidu (BIDU) as Hospital Union Seeks to End Online Ads
-
BlackBerry (BBRY) PT Cut at Nomura Ahead of Q4 Results
-
Nomura Has Positive View of Signet Jewelers Limited (SIG) Q4 Results
-
Francesca's Holdings (FRAN) PT Lifted to $19 at Nomura Following First Beat in 8 Quarters
-
Tekmira Announces Completion of Underwritten Public Offering of Common Shares
-
Tekmira Announces Completion of Underwritten Public Offering of Common Shares
-
Introducing Neo4j 2.2: The World's Fastest, Most Scalable Native Graph Database
-
Retrophin Closes Public Offering of 7,866,000 Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Great Wolf Resorts, Inc. to be Acquired by an Affiliate of Centerbridge Partners, L.P.
-
Form 6-K NOMURA HOLDINGS INC For: Mar 24
-
Notable 52-Week Highs and Lows 3/23: (PFE) (TEVA) (DRI) High; (MEIP) (SONS) (YOKU) Low
-
Youku.com (YOKU) PT Trimmed at Nomura; 'Buy' Maintained
-
Nomura Securities Downgrades Informatica (INFA) to Neutral
-
Nomura Securities Starts Tetraphase Pharmaceuticals (TTPH) at Buy, $54 PT
-
Streetinsider.com's Hot Lunchtime Reads 3/20: (FB) (GODY) (ICPT) (MGM)
-
Intercept (ICPT) 'Breaking Away from the Competition', Nomura Says
-
Nomura Securities Downgrades Randgold Resources Ltd. (GOLD) to Reduce
-
Tekmira Announces Pricing of Underwritten Public Offering of Common Shares
-
The Michaels Companies (MIK) PT Raised to $33 at Nomura Securities
-
Mattress Firm Holding (MFRM) PT Raised to $78 at Nomura Post Q4
-
Trial Design Likely Boosted Biogen (BIIB) BIIB037 Efficacy Data - Nomura

